课题基金 / 基金详情

MECHANISM OF CLEAVAGE SPECIFICITY OF ALZHEIMERS DISEASE

MECHANISM OF CLEAVAGE SPECIFICITY OF ALZHEIMERS DISEASE
阿尔茨海默病的裂解特异性机制
批准号:
6118269
负责人:
KONRAD BEYREUTHER
金额:
$0.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-10 至 1999-11-30

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The generation of the Aa-peptide requires the cleavage of its precursor A4CT (C99) by the so-far unidentified (-secretase. Since the position of (-secretase cleavage is crucial for the pathogenesis of Alzheimer's disease, we individually replaced all membrane domain residues of A4CT outside the Aa-domain by phenylalanine, stably transfected the constructs in COS7-cells and determined the effect of these mutations on the cleavage specificity of (-secretase (Aa42/Aa40-ratio). Compared to A4CT-wildtype, mutations at Val44, Ile47 and Val50 led to decreased Aa42/Aa40-ratios whereas mutations at Thr43, Ile45, Val46, Leu49 and Met51 led to increased Aa42/Aa40-ratios. The strongest effect was observed for Ile45Phe (34-fold increase) making this construct highly valuable for the generation of animal models for Alzheimer's disease. Unlike the other mutations, A4CT-V44F was mainly processed to Aa38 as determined by mass spectrometry. Our data provide for the first time a detai led possib le model for the active site of (-secretase: (-secretase interacts with the transmembrane domain of A4CT by binding to one side of the ?-helix. Mutations in the transmembrane domain of A4CT interfere with the interaction of (-secretase and A4CT. As a result, the cleavage specificity of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金